CVE:IOTInnovotech Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Innovotech Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add C$0.18 0.00 (0.00 %) (As of 07/3/2020 04:00 PM ET) Add Compare Share Today's RangeC$0.18Now: C$0.18▼C$0.1850-Day RangeC$0.15MA: C$0.18▼C$0.2252-Week RangeC$0.05Now: C$0.18▼C$0.28VolumeN/AAverage Volume44,305 shsMarket CapitalizationC$6.52 millionP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsEarningsInsider TradesHeadlinesSocial Media Innovotech Inc. provides services and solutions to medical, agricultural, and industrial problems caused by microbial biofilms in Canada and internationally. The company's products include InnovoSIL, the antimicrobial agents for coating onto or incorporation into medical devices; MBEC Assay, a screening assay used to determine the efficacy of antimicrobials against biofilms of various microorganisms; and Agress/AgreGuard, an environmentally friendly seed treatments and plant sprays to protect crops against both bacterial and fungal infections. Its products also include MBEC Assay's biofilm inoculator comprising plastic lids with 96 pegs to simulate the surface conditions on which microorganisms attach and grow. The company's services cover implant medical devices, bacteriophage and cytotoxicity testing, and in vitro antimicrobial testing, as well as antibiotic, antimicrobial, and biocide resistance. It serves customers in the areas of biofilm issues, including catheter and implant medical devices, antibiotic drug development, wound healing, paint and specialized coatings, water system antimicrobial agents, dental treatments and water line antimicrobial agents, and bacterial and fungal agricultural crop diseases, as well as disinfectants in food safety, transportation, and healthcare. The company is headquartered in Edmonton, Canada.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Innovotech. Previous Next 2.3 Community Rank Outperform VotesInnovotech has received 41 “outperform” votes. (Add your “outperform” vote.)Underperform VotesInnovotech has received 49 “underperform” votes. (Add your “underperform” vote.)Community SentimentInnovotech has received 54.44% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Innovotech and other stocks. Vote “Outperform” if you believe IOT will outperform the S&P 500 over the long term. Vote “Underperform” if you believe IOT will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldInnovotech does not currently pay a dividend.Dividend GrowthInnovotech does not have a long track record of dividend growth. Previous Next 3.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Innovotech insiders have bought more of their company's stock than they have sold. Specifically, they have bought C$2,750.00 in company stock and sold C$0.00 in company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Innovotech is -45.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Innovotech is -45.00, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Previous Next Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 3.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.06 out of 5 stars Industry, Sector and Symbol Stock Exchange CVE Industry Biotechnology Sub-IndustryN/A SectorMedical Current SymbolCVE:IOT Previous Symbol CUSIPN/A CIKN/A Webwww.incomeopp-realty.com Phone+1-780-4480585Debt Debt-to-Equity Ratio101.95 Current Ratio1.06 Quick Ratio0.83Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesC$890,591.00 Price / Sales7.32 Cash FlowC$0.00 per share Price / Cash Flow90.00 Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding Shares36,239,600Market CapC$6.52 million Next Earnings Date8/18/2020 (Estimated) OptionableNot Optionable TSXV:IOT Rates by TradingView Receive IOT News and Ratings via Email Sign-up to receive the latest news and ratings for IOT and its competitors with MarketBeat's FREE daily newsletter. Innovotech (CVE:IOT) Frequently Asked Questions How has Innovotech's stock been impacted by COVID-19 (Coronavirus)? Innovotech's stock was trading at C$0.12 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, IOT stock has increased by 56.5% and is now trading at C$0.18. View which stocks have been most impacted by Coronavirus. When is Innovotech's next earnings date? Innovotech is scheduled to release its next quarterly earnings announcement on Tuesday, August 18th 2020. View our earnings forecast for Innovotech. Has Innovotech been receiving favorable news coverage? News coverage about IOT stock has trended somewhat negative on Saturday, according to InfoTrie. The research group rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Innovotech earned a news sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an impact on the company's share price in the next several days. View the latest news about Innovotech. Who are some of Innovotech's key competitors? Some companies that are related to Innovotech include ContraVir Pharmaceuticals (HEPA), Fusion Antibodies (FAB), Bio-Gene Technology (BGT), Tissue Regenix Group (TRX), NovaBay Pharmaceuticals (NBY), Oragenics (OGEN), Bionomics (BNO), Hemogenyx Pharmaceuticals (HEMO), ImmuPharma (IMM), Acrux (ACR), Quest PharmaTech (QPT), Ceapro (CZO), Skinbiotherapeutics (SBTX), Actinogen Medical (ACW) and Exopharm (EX1). View all competitors. What other stocks do shareholders of Innovotech own? Based on aggregate information from My MarketBeat watchlists, some companies that other Innovotech investors own include Ecosciences (ECEZ), SMART CANNABIS/SH SH (SCNA), Nokia Oyj (NOK), Neptune Wellness Solutions (NEPT), Medmen Enterprises (MMNFF), ICC International Cannabis (KNHBF), International Lithium (ILC), Innovative Industrial Properties (IIPR), Crispr Therapeutics (CRSP) and Canopy Growth (CGC). Who are Innovotech's key executives? Innovotech's management team includes the following people: Dr. James Timourian, Chairman, CEO, Pres & Sec.Mr. Alan C. Savage, CFO & Director (Age 76)Dr. Amin Omar, Chief Operating OfficerDr. Merle Olson, Scientific Consultant What is Innovotech's stock symbol? Innovotech trades on the Canadian Venture Exchange (CVE) under the ticker symbol "IOT." How do I buy shares of Innovotech? Shares of IOT and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade, and Charles Schwab. What is Innovotech's stock price today? One share of IOT stock can currently be purchased for approximately C$0.18. How big of a company is Innovotech? Innovotech has a market capitalization of C$6.52 million and generates C$890,591.00 in revenue each year. What is Innovotech's official website? The official website for Innovotech is www.incomeopp-realty.com. How can I contact Innovotech? Innovotech's mailing address is Suite 101, 2011-94 Street, EDMONTON, AB T6N 1H1, Canada. The company can be reached via phone at +1-780-4480585. This page was last updated on 7/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
